Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo (Q39782062)

14 September 2017

Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo (English)

1 reference

14 September 2017

Joslyn Mills

1

1 reference

14 September 2017

Tulio Matos

2

1 reference

14 September 2017

Elizabeth Charytonowicz

3

1 reference

14 September 2017

Todd Hricik

4

1 reference

14 September 2017

Mireia Castillo-Martin

5

1 reference

14 September 2017

Fabrizio Remotti

6

1 reference

14 September 2017

Francis Y Lee

7

1 reference

14 September 2017

Igor Matushansky

8

1 reference

14 September 2017

1 November 2009

1 reference

14 September 2017

1 reference

14 September 2017

22

1 reference

14 September 2017

4

1 reference

14 September 2017

85-93

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1749-0774.2009.00073.x

14 September 2017

0 references

cites work

Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Mechanisms of sarcomagenesis.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

22 September 2017

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000410

p53 Mutation and MDM2 amplification in human soft tissue sarcomas

2 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19874397

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19874397

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1749-0774.2009.00073.X

1 reference

Dimensions Publication ID

14 September 2017

1007322914

0 references

Fatcat ID

release_yexcbwfsubddbop4sfrzzs744y

0 references

1 reference

14 September 2017

1 reference